Primatene Mist inhalers (epinephrine inhalation aerosol) provide temporary relief from mild, intermittent asthma symptoms.

Net income for Q2 totaled $37.9 million (20.8%). The beat was largely the result of continued strength from epinephrine and Primatene MIST. As evidenced by Amphastar's other products, such as ...

Although the revenue and EPS for Amphastar (AMPH) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall ...

Amphastar Pharmaceuticals Inc (AMPH) reports a 6% revenue increase, driven by record Primatene Mist sales, despite facing competitive and logistical hurdles.

This study aims to determine whether a subpopulation of children with croup, given mist and dexamethasone, can be treated with nebulized racemic epinephrine and safely discharged after observation ...